Clinical Trials Directory

Trials / Completed

CompletedNCT05479201

Prevalence of Obstructive Sleep Apnoea (OSA) Among 4-8 Years Old Children in the General Population

Status
Completed
Phase
Study type
Observational
Enrollment
386 (actual)
Sponsor
Akureyri Hospital · Other Government
Sex
All
Age
4 Years – 8 Years
Healthy volunteers

Summary

The purpose of this study is to estimated prevalence of obstructive sleep apnea (OSA) in 4-8 year old children. To date, most studies estimating prevalence of sleep apnea in young children are based on utilizing subjective questionnaires. The few studies that have utilized objective sleep measures have tested only those children suspected of sleep apnea based on subjective questionnaires, finding prevalence in the range of 1-13%. Untreated OSA is associated with significant morbidities in children, affecting their behavior, cognitive development, cardiovascular-and cardio metabolic health, endocrine and immune function. Better understanding of prevalence of sleep apnea in young children should be beneficial. This study will help to understand the prevalence of sleep apnea in each age-group of children 4-8 years of age and whether certain groups, such as children with obesity or asthma have higher prevalence and/or more severe disease. The primary objective of this study is to get better understanding of prevalence and severity of sleep apnea in young children using objective sleep measures for all participants.

Detailed description

The study is a population-based, observational study of 4-8 year old children located in Akureyri, Iceland. All parents in this geographical area will be invited for their child/children to participate in the study. Parents of all participating children will be asked to answer questionnaires to assess general health, sleep habits, behavior and quality of life and then measure their sleep for five consecutive nights with a home based sleep test.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHome based sleep testHome based sleep test to calculate apnea hypopnea index (AHI) for evaluation of sleep apnea, sleep quality (SQI) and sleep duration (SD)

Timeline

Start date
2022-08-05
Primary completion
2023-06-15
Completion
2023-06-30
First posted
2022-07-29
Last updated
2023-07-13

Locations

1 site across 1 country: Iceland

Source: ClinicalTrials.gov record NCT05479201. Inclusion in this directory is not an endorsement.